Frontiers in oncology.

Frontiers Jan 9, 2024 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. Precision Medicine in Oncology. Recent advances in technology have unveiled a tremendous heterogeneity in cancer dysfunctional mechanisms. This gain of knowledge has opened a new era in oncology, which relays on the concept that each tumor is different and should be treated in a specific way depending on its distinctive …Explore the impact and performance of Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the number of citations, articles, views, …Frontiers articles are indexed in a number of major international digital archives and repositories, such as PubMed Central, DOAJ, Google Scholar, Chemical Abstracts Service. For additional details on specific indexing, please see the individual journals’ About page.

Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of …Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...

Molecular Landscapes of Human Papillomavirus-Related Squamous Cell Carcinoma. Jinhui Liu. Jianguang Ji. Liang Zhou. 12,031 views. 6 articles. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.Learn how to prepare and submit your manuscript to Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the articl…

Dec 19, 2023 ... Ministry of Education Frontiers Science Center for Precision Oncology of UM holds its first Academic Committee meeting, academicians and ...SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.mohammad athar. University of Alabama at Birmingham. Birmingham, United States. Specialty Chief Editor. Skin Cancer.Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.Mar 3, 2023 ... Ministry of Education Frontiers Science Center for Precision Oncology Seminar Series 2023_05. 2023-03-03.

Watch live sports for free

Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ...

Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...May 8, 2024 · Yutaka Tamura. Kengo Yoshii. Tomoharu Sugie. Mitsugu Sekimoto. Frontiers in Oncology. doi 10.3389/fonc.2024.1365305. 844 views. This section explores high-quality research concerning all aspects of cancer and benign neoplasm drug treatment. priya ranjit bhosale. University of Texas MD Anderson Cancer Center. Houston, United States. Associate Editor. Gynecological Oncology.Feb 28, 2023 ... In an initial trial, patients who were in remission after previously having cancer were vaccinated, with the goal of preventing recurrence. Now, ... Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.

4 Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia 5 Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia Chemotherapy has historically been the mainstay of cancer treatment, but our understanding of what drives a successful therapeutic response remains limited.liang qiao. Faculty of Medicine and Health, The University of Sydney. Sydney, Australia. Specialty Chief Editor. Gastrointestinal Cancers: Colorectal Cancer.32. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz JF, Paillaud E, et al. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer (2023) 23(1):17. doi: …1 Introduction. Colorectal cancer (CRC) is the third most common cancer worldwide (colon: 1,148,515; rectum: 732,210) and the second leading cause of cancer-related deaths (colon: 935,000; rectum: 339,022) in 2020.There were about 555,000 new cases of colorectal cancer in China in 2020, accounting for 12.2% of the number of new …1 Hookipa Pharma Inc., New York, NY, United States; 2 Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, Basel, Switzerland; Engineered viral vectors represent a promising strategy to trigger antigen-specific antitumor T cell responses. Arenaviruses have been widely studied … Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...

2.1 Characterization of Resistance in Cancer. Drug resistance in cancer is an intimate occurrence that results when cancer becomes tolerant of pharmaceutical treatment ().An extensive range of factors contributes to the development of resistance against anticancer drugs, including genetic mutations, altered epigenetics, enhanced drug efflux, …Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ...

Available at: https://persistent-url (Accessed March 15, 2018). This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. Precision Medicine in Oncology. Recent advances in technology have unveiled a tremendous heterogeneity in cancer dysfunctional mechanisms. This gain of knowledge has opened a new era in oncology, which relays on the concept that each tumor is different and should be treated in a specific way depending on its distinctive …本文介绍了瑞士期刊《Frontiers in Oncology》的发展历程、影响因子、发文量、审稿速度、版面费等情况，以及该刊的优缺点和投稿建议。该刊是一本涵盖肿瘤癌症各个领域的开 …Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.Video-Assisted Surgery in Oncology. Cancer is a leading cause of death and main contributor for disease burden globally. To treat the majority of cancer types, surgery is the only curable strategy for patients at an earlier stage; it also can be used for palliative care when patients are at a later stage. Video-assisted surgery (VAS) has been ... Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ...

How do you create a new email

May 10, 2024 · Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology.

The Potential of Photoacoustic Imaging in Radiation Oncology. Thierry L. Lefebvre 1,2 Emma Brown 1,2 Lina Hacker 1,2 Thomas Else 1,2 Mariam-Eleni Oraiopoulou 1,2 Michal R. Tomaszewski 3† Rajesh Jena 4 Sarah E. Bohndiek 1,2*. 1 Department of Physics, University of Cambridge, Cambridge, United Kingdom. 2 Cancer Research UK …The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ...Integrative oncology becomes a critical component of evidence-informed, patient-centered cancer care, helping patients and their families navigate the ...timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology.Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ).Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.Quan Yuan. Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.本文介绍了瑞士期刊《Frontiers in Oncology》的发展历程、影响因子、发文量、审稿速度、版面费等情况，以及该刊的优缺点和投稿建议。该刊是一本涵盖肿瘤癌症各个领域的开 …Frontiers' open access policy ensures high visibility and maximum exposure of your work - anyone can read your Frontiers articles, without paying any access or subscription costs. Your work can be shared under the terms of the Creative Commons Attribution License. Frontiers submits all its journals for archiving in PubMed Central and PubMed ...4 days ago · Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …

4 Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia 5 Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia Chemotherapy has historically been the mainstay of cancer treatment, but our understanding of what drives a successful therapeutic response remains limited.Visitors may also download and forward articles subject to the citation requirements and subject to any fees POR's publisher, Frontiers, may charge for ...Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and...Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Instagram:https://instagram. ace attorney trilogy This Frontiers in Oncology Special Issue marks the 1st edition of a collection of selected articles published in the journal over the course of the previous calendar year, highlighting ongoing research and advances being carried out in the different disciplines of cancer research.Frontiers in Oncology. doi 10.3389/fonc.2024.1370059. 249 views Original Research. Published on 26 Apr 2024 Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis. in Radiation Oncology. Simon K. B. Spohn; kc to denver Video-Assisted Surgery in Oncology. Cancer is a leading cause of death and main contributor for disease burden globally. To treat the majority of cancer types, surgery is the only curable strategy for patients at an earlier stage; it also can be used for palliative care when patients are at a later stage. Video-assisted surgery (VAS) has been ... wip fm radio Survival of 48866 cancer patients: results from Nantong area, China. Objective: This study aimed to provide a realistic observation of survival by major site for 48,866 cancer patients treated at a tertiary cancer hospital in a rural area of China. Methods: Patients with cancer registered between 2007 and 2017 in the Nantong rural … fresno state game In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health … air ticket to iceland Reviews should present a complete overview of the state of the art (and should not merely summarize the literature), as well as discuss the following: 1) Different schools of thought or controversies, 2) Fundamental concepts, issues, and problems, 3) Current research gaps, 4) Potential developments in the field.Special Issue Information. Dear Colleagues,. Pancreatic adenocarcinoma is an aggressive malignancy associated with poor prognosis and is the fourth most common ... caps to lowercase Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order. Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast ... wsfa news live This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.Dongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia.How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research. chick fil a o List of posts by tag Frontiers in Oncology freight tools harbor freight A future TCR-T therapy encompassing multiple innovations is illustrated in Figure 15, as an example of the driving force in the E2E Platform applied across multiple modules to support the goal of developing differentiated, best-in-class TCR-T therapies as new and better treatment options for cancer patients. fastest indian film markus brunner. Medical University of Vienna. Vienna, Austria. Associate Editor. Head and Neck Cancer. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes. sirius customer service Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ...SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different disciplines.